479 related articles for article (PubMed ID: 27431223)
21. Antifungal resistance of Candida glabrata vaginal isolates and development of a quantitative reverse transcription-PCR-based azole susceptibility assay.
Gygax SE; Vermitsky JP; Chadwick SG; Self MJ; Zimmerman JA; Mordechai E; Adelson ME; Trama JP
Antimicrob Agents Chemother; 2008 Sep; 52(9):3424-6. PubMed ID: 18591262
[TBL] [Abstract][Full Text] [Related]
22. The ATP binding cassette transporter gene CgCDR1 from Candida glabrata is involved in the resistance of clinical isolates to azole antifungal agents.
Sanglard D; Ischer F; Calabrese D; Majcherczyk PA; Bille J
Antimicrob Agents Chemother; 1999 Nov; 43(11):2753-65. PubMed ID: 10543759
[TBL] [Abstract][Full Text] [Related]
23. Ibuprofen reverts antifungal resistance on Candida albicans showing overexpression of CDR genes.
Ricardo E; Costa-de-Oliveira S; Dias AS; Guerra J; Rodrigues AG; Pina-Vaz C
FEMS Yeast Res; 2009 Jun; 9(4):618-25. PubMed ID: 19416368
[TBL] [Abstract][Full Text] [Related]
24. Antagonism of azole activity against Candida albicans following induction of multidrug resistance genes by selected antimicrobial agents.
Henry KW; Cruz MC; Katiyar SK; Edlind TD
Antimicrob Agents Chemother; 1999 Aug; 43(8):1968-74. PubMed ID: 10428921
[TBL] [Abstract][Full Text] [Related]
25. Resensitization of Fluconazole-Resistant Urinary
Edward EA; Mohamed NM; Zakaria AS
Pol J Microbiol; 2020 Sep; 69(1):73-84. PubMed ID: 32189482
[TBL] [Abstract][Full Text] [Related]
26. Mechanisms of fluconazole resistance in Candida albicans isolates from Japanese AIDS patients.
Maebashi K; Niimi M; Kudoh M; Fischer FJ; Makimura K; Niimi K; Piper RJ; Uchida K; Arisawa M; Cannon RD; Yamaguchi H
J Antimicrob Chemother; 2001 May; 47(5):527-36. PubMed ID: 11328762
[TBL] [Abstract][Full Text] [Related]
27. Relative contributions of the Candida albicans ABC transporters Cdr1p and Cdr2p to clinical azole resistance.
Tsao S; Rahkhoodaee F; Raymond M
Antimicrob Agents Chemother; 2009 Apr; 53(4):1344-52. PubMed ID: 19223631
[TBL] [Abstract][Full Text] [Related]
28. Resistance mechanisms in fluconazole-resistant Candida albicans isolates from vaginal candidiasis.
Cernicka J; Subik J
Int J Antimicrob Agents; 2006 May; 27(5):403-8. PubMed ID: 16621465
[TBL] [Abstract][Full Text] [Related]
29. Vanillin confers antifungal drug synergism in Candida albicans by impeding CaCdr2p driven efflux.
Saibabu V; Fatima Z; Singh S; Khan LA; Hameed S
J Mycol Med; 2020 Apr; 30(1):100921. PubMed ID: 31937429
[TBL] [Abstract][Full Text] [Related]
30. An Azole-Tolerant Endosomal Trafficking Mutant of Candida albicans Is Susceptible to Azole Treatment in a Mouse Model of Vaginal Candidiasis.
Peters BM; Luna-Tapia A; Tournu H; Rybak JM; Rogers PD; Palmer GE
Antimicrob Agents Chemother; 2017 Jun; 61(6):. PubMed ID: 28348159
[TBL] [Abstract][Full Text] [Related]
31. [Investigation of mutations in transcription factors of efflux pump genes in fluconazole-resistant Candida albicans strains overexpressing the efflux pumps].
Kalkandelen KT; Doluca Dereli M
Mikrobiyol Bul; 2015 Oct; 49(4):609-18. PubMed ID: 26649419
[TBL] [Abstract][Full Text] [Related]
32. New evidence that Candida albicans possesses additional ATP-binding cassette MDR-like genes: implications for antifungal azole resistance.
Walsh TJ; Kasai M; Francesconi A; Landsman D; Chanock SJ
J Med Vet Mycol; 1997; 35(2):133-7. PubMed ID: 9147273
[TBL] [Abstract][Full Text] [Related]
33. Expression of fluconazole resistance-associated genes in biofilm from 23 clinical isolates of Candida albicans.
Shi C; Liu J; Li W; Zhao Y; Meng L; Xiang M
Braz J Microbiol; 2019 Jan; 50(1):157-163. PubMed ID: 30617866
[TBL] [Abstract][Full Text] [Related]
34. Mechanism of fluconazole resistance in Candida albicans biofilms: phase-specific role of efflux pumps and membrane sterols.
Mukherjee PK; Chandra J; Kuhn DM; Ghannoum MA
Infect Immun; 2003 Aug; 71(8):4333-40. PubMed ID: 12874310
[TBL] [Abstract][Full Text] [Related]
35. A prenylated flavanone from Dalea elegans inhibits rhodamine 6 G efflux and reverses fluconazole-resistance in Candida albicans.
Peralta MA; Calise M; Fornari MC; Ortega MG; Diez RA; Cabrera JL; Pérez C
Planta Med; 2012 Jun; 78(10):981-7. PubMed ID: 22673834
[TBL] [Abstract][Full Text] [Related]
36. Prevalence of molecular mechanisms of resistance to azole antifungal agents in Candida albicans strains displaying high-level fluconazole resistance isolated from human immunodeficiency virus-infected patients.
Perea S; López-Ribot JL; Kirkpatrick WR; McAtee RK; Santillán RA; Martínez M; Calabrese D; Sanglard D; Patterson TF
Antimicrob Agents Chemother; 2001 Oct; 45(10):2676-84. PubMed ID: 11557454
[TBL] [Abstract][Full Text] [Related]
37. Azole resistance in a
Khandelwal NK; Chauhan N; Sarkar P; Esquivel BD; Coccetti P; Singh A; Coste AT; Gupta M; Sanglard D; White TC; Chauvel M; d'Enfert C; Chattopadhyay A; Gaur NA; Mondal AK; Prasad R
J Biol Chem; 2018 Jan; 293(2):412-432. PubMed ID: 29158264
[TBL] [Abstract][Full Text] [Related]
38. Regulated overexpression of CDR1 in Candida albicans confers multidrug resistance.
Niimi M; Niimi K; Takano Y; Holmes AR; Fischer FJ; Uehara Y; Cannon RD
J Antimicrob Chemother; 2004 Dec; 54(6):999-1006. PubMed ID: 15486081
[TBL] [Abstract][Full Text] [Related]
39. Positive regulation of the Candida albicans multidrug efflux pump Cdr1p function by phosphorylation of its N-terminal extension.
Tsao S; Weber S; Cameron C; Nehme D; Ahmadzadeh E; Raymond M
J Antimicrob Chemother; 2016 Nov; 71(11):3125-3134. PubMed ID: 27402010
[TBL] [Abstract][Full Text] [Related]
40. Heterozygosity and functional allelic variation in the Candida albicans efflux pump genes CDR1 and CDR2.
Holmes AR; Tsao S; Ong SW; Lamping E; Niimi K; Monk BC; Niimi M; Kaneko A; Holland BR; Schmid J; Cannon RD
Mol Microbiol; 2006 Oct; 62(1):170-86. PubMed ID: 16942600
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
